AR045745A1 - Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2 - Google Patents

Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2

Info

Publication number
AR045745A1
AR045745A1 ARP040103272A ARP040103272A AR045745A1 AR 045745 A1 AR045745 A1 AR 045745A1 AR P040103272 A ARP040103272 A AR P040103272A AR P040103272 A ARP040103272 A AR P040103272A AR 045745 A1 AR045745 A1 AR 045745A1
Authority
AR
Argentina
Prior art keywords
milk
prevention
treatment
diseases mediated
cox
Prior art date
Application number
ARP040103272A
Other languages
English (en)
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34130196&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR045745(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of AR045745A1 publication Critical patent/AR045745A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)

Abstract

Composiciones nutricionales y farmacéuticas para el tratamiento y prevención de enfermedades mediadas por la ciclooxigenasa 2 y a un método para incrementar la actividad inhibidora de ciclooxigenasa 2 de un producto. El uso de una o más fracciones de proteína de leche y/o una o más preparaciones de proteína de leche para inhibir la actividad de ciclooxigenasa 2 (COX-2), en particular para la preparación de un medicamento o un alimento funcional para el tratamiento y la prevención de enfermedades mediadas por la ciclooxigenasa 2.
ARP040103272A 2003-09-12 2004-09-13 Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2 AR045745A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03020739.3A EP1514482B2 (en) 2003-09-12 2003-09-12 Milk fractions and milk preparations for treating and/or preventing COX-2 mediated diseases

Publications (1)

Publication Number Publication Date
AR045745A1 true AR045745A1 (es) 2005-11-09

Family

ID=34130196

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103272A AR045745A1 (es) 2003-09-12 2004-09-13 Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2

Country Status (16)

Country Link
US (1) US8012509B2 (es)
EP (2) EP1955602B1 (es)
JP (1) JP4824560B2 (es)
CN (1) CN1849076B (es)
AR (1) AR045745A1 (es)
AT (1) ATE407574T2 (es)
AU (1) AU2004271722B2 (es)
BR (1) BRPI0413714A (es)
CA (1) CA2537544C (es)
CR (1) CR8265A (es)
DE (1) DE60323489D1 (es)
ES (1) ES2314152T3 (es)
MX (1) MXPA06002648A (es)
PT (1) PT1514482E (es)
TW (1) TW200524545A (es)
WO (1) WO2005025335A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951064B2 (en) 2005-11-14 2020-05-13 Société des Produits Nestlé S.A. Oral tolerance promotion with glycated proteins
NL1033698C2 (nl) * 2007-04-16 2008-10-20 Friesland Brands Bv Functioneel serumeiwitproduct voor toepassing in kindervoeding en therapeutische samenstellingen, en werkwijzen ter bereiding daarvan.
US20080293159A1 (en) * 2007-05-24 2008-11-27 Murray Goulburn Co-Operative Co. Ltd. Validation Process
WO2011044628A1 (en) * 2009-10-16 2011-04-21 Dairy Australia Limited Allergy treatment using acid treated aqueous whey protein extract
WO2012050895A1 (en) * 2010-09-28 2012-04-19 Lisa Geng Methods for treating neurological disorders using nutrient compositions
US9931365B2 (en) 2010-09-28 2018-04-03 Lisa Geng Methods for treating neurological disorders using nutrient compositions
CN105613731B (zh) * 2016-03-17 2019-12-31 广西壮族自治区水牛研究所 一种发酵乳制品
DE112019002696A5 (de) * 2018-05-30 2021-02-18 DÖHLER GmbH Hochdruckverfahren, insbesondere zur Haltbarmachung von Lebensmitteln, Pharmazeutika und Kosmetika sowie Hochdruckvorrichtung
WO2020159357A1 (en) * 2019-02-01 2020-08-06 N.V. Nutricia Native whey protein for treating and/or preventing intestinal infection

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748847A1 (de) * 1976-11-05 1978-05-11 Stauffer Chemical Co Verfahren zum verstaerken saurer alkoholfreier getraenke mit protein und verstaerkungsmittel auf proteinbasis
US4358464A (en) * 1977-08-02 1982-11-09 Superior Dairy, Inc. Process for converting sour whey into sweet whey and product
US4284623A (en) 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
DE3141914A1 (de) * 1981-10-22 1983-05-05 Babcock-BSH AG vormals Büttner-Schilde-Haas AG, 4150 Krefeld Verfahren zur herstellung von frischkaese
JPS6339545A (ja) * 1986-08-04 1988-02-20 Meiji Milk Prod Co Ltd 牛乳ホエ−中のβ−ラクトグロブリンの除去方法
JP2622686B2 (ja) * 1987-05-15 1997-06-18 雪印乳業株式会社 ｋ−カゼイングリコマクロペプチドの製造法
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
US5888552A (en) 1988-04-29 1999-03-30 Immunotec Research Corporation Ltd. Anti-cancer therapeutic compositions containing whey protein concentrate
AUPN271295A0 (en) * 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
DE4413839C1 (de) 1994-04-21 1995-10-19 Fritz Koch Pharma Gmbh Dr Med Kombinationspräparat
DE19649891C2 (de) * 1996-12-02 1998-12-10 Mk Produktkontor Gmbh Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
DE19726868A1 (de) * 1997-06-24 1999-01-07 Mk Produktkontor Gmbh Antioxidative Zusammensetzungen mit Süßmolkekonzentrat
ATE322275T1 (de) * 1998-06-10 2006-04-15 Albert B Crum Vorbeugender und therapeutischer nahrungsmittelzusatz zur schaffung/erhaltung einer die gesundheit schützenden darmmikroflora und zur stärkung des immunsystems
US6558716B1 (en) * 1999-01-14 2003-05-06 Kraft Foods Holdings, Inc. Process for incorporating whey protein into cheese
DE19918210A1 (de) 1999-04-22 2000-11-02 Biomun Gmbh Verfahren zur Herstellung eines Milchpräparates mit verzögerter Inhaltsstoff-Freisetzung und seine Verwendung
DE19918219C1 (de) * 1999-04-22 2001-01-18 Dornier Gmbh Lebensdauer-Indikator für hochbeanspruchte Leichtbau-Strukturen
CN100413423C (zh) * 1999-04-29 2008-08-27 雀巢制品公司 用于具有低苏氨酸含量的婴儿配制食品的组合物
US6469063B1 (en) * 1999-11-18 2002-10-22 City Of Hope Inhibition of inflammation via inhibition of COX-2 gene transcription
GB0002312D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
FR2808444B1 (fr) * 2000-05-05 2004-03-26 Francois Ballestra Utilisation d'une fraction du lait d'equide pour la fabrication d'une composition possedant une activite d'inhibition de la production de l'interleukine-1 et composition ainsi obtenue
US6465509B2 (en) * 2000-06-30 2002-10-15 Merck Frosst Canada & Co. Pyrones as inhibitors of cyclooxygenase-2
BR0116415A (pt) * 2000-12-22 2003-12-30 Nestle Sa Indução de toler ncia
US20020169195A1 (en) * 2001-01-26 2002-11-14 George Kindness Combination and method of treatment of cancer utilizing a COX-2 inhibitor and an HMG-CoA inhibitor and cystine to enhance glutathione
US6589574B2 (en) * 2001-03-19 2003-07-08 Council Of Scientific & Industrial Research Process for preparation of protein-hydrolysate from milk protein
US20030026845A1 (en) * 2001-06-18 2003-02-06 Etzel Lisa R. Process for preparing protein isolate from milk, whey, colostrum, and the like
FR2827290B1 (fr) * 2001-07-13 2004-07-09 Pierre Jouan Biotechnologies Sa Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques
DE10208034A1 (de) * 2002-02-26 2003-09-11 Helmut Otten Medikament sowie kosmetische und dermatologische Zubereitung enthaltend ein Büffelmilchprodukt

Also Published As

Publication number Publication date
CA2537544C (en) 2012-12-11
CN1849076A (zh) 2006-10-18
EP1955602B1 (en) 2018-04-04
ES2314152T3 (es) 2009-03-16
CR8265A (es) 2006-07-14
AU2004271722B2 (en) 2010-12-16
WO2005025335A1 (en) 2005-03-24
EP1514482B2 (en) 2016-06-22
DE60323489D1 (de) 2008-10-23
ATE407574T2 (de) 2008-09-15
AU2004271722A1 (en) 2005-03-24
MXPA06002648A (es) 2006-06-05
CN1849076B (zh) 2010-06-09
US8012509B2 (en) 2011-09-06
JP2007505078A (ja) 2007-03-08
JP4824560B2 (ja) 2011-11-30
CA2537544A1 (en) 2005-03-24
US20070110818A1 (en) 2007-05-17
EP1514482B1 (en) 2008-09-10
BRPI0413714A (pt) 2006-10-17
TW200524545A (en) 2005-08-01
EP1955602A1 (en) 2008-08-13
EP1514482A1 (en) 2005-03-16
PT1514482E (pt) 2008-11-19

Similar Documents

Publication Publication Date Title
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
CR8265A (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de enfermedades mediadas por cox-2
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
UA88165C2 (en) Use of trisubstituted benzopyranones
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
BRPI0516545A (pt) uso de óleo de lavanda para a profilaxia e tratamento de neurastenia, distúrbios de somatização e outras doenças associadas ao estresse
WO2004075867A3 (de) Zubereitungen eines extraktes von eperua falcata und/oder dessen inhaltstoffe enthaltend
WO2004006911A3 (fr) Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations
FR2855721B1 (fr) Microbicide antiseptique, et cosmetique, medicament et aliment incorporant ledit microbicide antiseptique
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
DE602004025103D1 (de) Heilkräuterzusammensetzung zur Behandlung von AIDS
FR2857222B1 (fr) Microbicide antiseptique, et cosmetique, medicament et aliment incorporant ledit microbicide antiseptique
ATE499093T1 (de) Zusammensetzung auf citicolin-basis in kombination mit vitaminen zur prävention und behandlung von augenerkrankungen
DE602004008051D1 (de) Aus einer bifidobakterien-kultur gewonnener immunomodulator und diesen enthaltende zusammensetzungen
HUP0204209A2 (hu) Készítmények lipidmetabolizmus-rendellenességek és allergiás formák megelőzésére és/vagy kezelésére
TH78148A (th) ลำดับส่วนของนมและส่วนเตรียมของนมสำหรับการรักษาและ/หรือการป้องกันโรคที่สื่อโดย cox-2
RU2006129597A (ru) Применение ксенона для предотвращения процессов перекисного окисления липидов в пищевых и косметических продуктах, в том числе обогащенных биологически активными веществами
TH78148B (th) ลำดับส่วนของนมและส่วนเตรียมของนมสำหรับการรักษาและ/หรือการป้องกันโรคที่สื่อโดย cox-2
Masoumzadeh et al. Study on the effects of applying Garlic (Allium sativum) and Zataria multiflora extracts on Aeromonas hydrophila in Persian sturgeon (Acipenser persicus) fingerling
DE50213300D1 (de) Antimikrobielle bolisinpeptide
UA4698U (uk) Засіб для лікування проктологічних захворювань - фітокрем "домашній цілитель"
ES2170654B1 (es) Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal